You have 9 free searches left this month | for more free features.

ogx-427

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer, Metastatic Castrate-Resistant Prostate Cancer, PSA Trial in Canada, United States (OGX-427, Abiraterone

Terminated
  • Prostate Cancer
  • +2 more
  • OGX-427
  • +2 more
  • Marina Del Rey, California
  • +15 more
Jul 7, 2022

Bladder Cancer, Urothelial Carcinoma Trial in United States (OGX-427, Docetaxel)

Completed
  • Bladder Cancer
  • Urothelial Carcinoma
  • Birmingham, Alabama
  • +34 more
Jul 7, 2022

Castration Resistant Prostate Cancer Trial in Canada, United States (OGX-427, Prednisone)

Completed
  • Castration Resistant Prostate Cancer
  • Seattle, Washington
  • +5 more
Feb 12, 2019

Non Squamous Non Small Cell Lung Cancer Trial in United States (OGX-427, Placebo)

Completed
  • Non Squamous Non Small Cell Lung Cancer
  • OGX-427
  • Placebo
  • Denver, Colorado
  • +15 more
Jun 6, 2018

Pancreatic Cancer Trial in United States (OGX-427, Placebo)

Completed
  • Pancreatic Cancer
  • OGX-427
  • Placebo
  • San Francisco, California
  • +10 more
Apr 11, 2017

Tumors Trial in Seattle, Vancouver, Hamilton (OGX-427, Docetaxel)

Completed
  • Neoplasms
  • Seattle, Washington
  • +2 more
Jan 14, 2016

Bladder Cancer Trial in Vancouver (OGX-427)

Unknown status
  • Bladder Cancer
  • OGX-427
  • Vancouver, British Columbia, Canada
    The Prostate Centre at Vancouver General Hospital
Feb 10, 2012